{
  "id": 4102503,
  "title": "Ambiq Micro CTO Scott Hanson sells $3.28m in AMBQ stock",
  "url": "https://urgent.news/2026/08/29/ambiq-micro-cto-scott-hanson-sells-3-28m-in-ambq-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-29T04:01:19.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ambiq-micro-cto-scott-hanson-sells-328m-in-ambq-stock-93CH-4881933"
  },
  "original_language": "en",
  "account": "Ambiq Micro's Chief Technology Officer, Scott McLean Hanson, divested a substantial portion of his company's stock, totaling over $3.28 million, according to a recent filing. The sales were executed on August 26 and 27, 2026, involving the exercise of stock options. Despite the stock currently trading at $57.34, which is below its 52-week high of $91.61, Ambiq Micro has achieved a robust 101% return year-to-date. However, InvestingPro analysis indicates the stock is overvalued, placing it among the Most Overvalued companies. Hanson's initial purchase of 37,500 shares on August 26 for $8.12 per share amounted to $304,500. He subsequently sold 27,500 shares on the same day at a weighted average price of $59.58 per share, generating approximately $1,638,469.25. The following day, Hanson acquired another 27,500 shares at $8.12 per share, totaling $223,300. He then sold 22,590 shares at a weighted average price of $59.69 per share, yielding about $1,348,369.30. In total, Hanson acquired common stock valued at $527,799 and sold 54,910 shares for a combined value of $3,283,078 across the two days. As a result, Hanson now owns 221,226 shares of Ambiq Micro directly, in addition to derivative securities. Ambiq Micro reported impressive second-quarter earnings, with revenue increasing by 89.7% to $33.9 million, marking its fifth consecutive quarter of growth. Driven by the increasing demand for edge AI chips, the company has revised its full-year sales outlook to approximately $135 million. UBS and BofA Securities have adjusted their price targets for Ambiq Micro, with UBS raising it to $73 and BofA to $75, citing strong demand and growth in edge-AI applications. Despite these positive developments, BofA maintains an Underperform rating. The company's management highlighted accelerating momentum in wearables and emerging applications in medical, industrial, and smart-home sectors. BofA also noted that demand for Ambiq Micro's components currently exceeds supply, reinforcing their view on the company's unit-led growth.",
  "summary": null,
  "key_points": [
    "Ambiq Micro CTO Scott Hanson sold $3.28 million in AMBQ stock",
    "Hanson bought 37,500 shares at $8.12 each on August 26",
    "Ambiq Micro reported 89.7% Q2 revenue growth to $33.9 million"
  ],
  "editors_take": "The sale of over $3.28 million in Ambiq Micro stock by CTO Scott Hanson comes as the company's impressive growth and strong demand for edge AI chips drive analyst price target increases.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}